Potential Therapeutic Relevance of CRISPR/Cas9 Guided Epigenetic Reg-ulations for Neuropsychiatric Disorders
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Singh, D.D. | - |
dc.contributor.author | Verma, R. | - |
dc.contributor.author | Parimoo, P. | - |
dc.contributor.author | Sahu, A. | - |
dc.contributor.author | Kumar, V. | - |
dc.contributor.author | Upadhyay, E. | - |
dc.contributor.author | Yadav, D.K. | - |
dc.date.accessioned | 2021-08-30T00:41:22Z | - |
dc.date.available | 2021-08-30T00:41:22Z | - |
dc.date.created | 2021-07-27 | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 1568-0266 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/81953 | - |
dc.description.abstract | Brain function activity is regulated by several mechanisms of genetic and epigenetic fac-tors such as histone modelling, DNA methylation, and non-coding RNA. Alterations in these regulatory mechanisms affect the normal development of neurons that causes Neuropsychiatric Disorders (ND). However, it is required to analyse the functional significance of neuropsychiatric disorders associated with a molecular mechanism to bring about therapeutic advances in early diagnosis and treatment of the patients. The CRISPR/Cas 9 (Clustered Regularly Interspaced Short Palin-dromic Repeats) genome editing tools have revolutionized multiple genome and epigenome manipulation targets the same time. This review discussed the possibilities of using CRISPR/Cas 9 tools during molecular mechanism in the ND as a therapeutic approach to overcome ND that is caused due to genetic and epigenetic abnormalities. © 2021 Bentham Science Publishers. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Bentham Science Publishers | - |
dc.relation.isPartOf | Current Topics in Medicinal Chemistry | - |
dc.title | Potential Therapeutic Relevance of CRISPR/Cas9 Guided Epigenetic Reg-ulations for Neuropsychiatric Disorders | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000687220700004 | - |
dc.identifier.doi | 10.2174/1568026621666210317154502 | - |
dc.identifier.bibliographicCitation | Current Topics in Medicinal Chemistry, v.21, no.10, pp.878 - 894 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85105255557 | - |
dc.citation.endPage | 894 | - |
dc.citation.startPage | 878 | - |
dc.citation.title | Current Topics in Medicinal Chemistry | - |
dc.citation.volume | 21 | - |
dc.citation.number | 10 | - |
dc.contributor.affiliatedAuthor | Yadav, D.K. | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | CRISPR/Cas9 | - |
dc.subject.keywordAuthor | Epigenetic regulations | - |
dc.subject.keywordAuthor | Gene editing | - |
dc.subject.keywordAuthor | Neuronal development | - |
dc.subject.keywordAuthor | Neuropsychiatric Disorders | - |
dc.subject.keywordAuthor | Therapeutic applications | - |
dc.subject.keywordAuthor | Transcription factor | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.